Showing results (1391-1400 of 1,431) with videos related to
Sort By:
Pageof 144
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)John T-A Hsu, Teng-Kuang Yeh, Shih-Chieh Yen, et al.American Heart Journal|December 28, 2020
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trialAshish Sarraju, JingWei Li, Christopher P Cannon, et al.JAMA Network Open|February 3, 2021
Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous ThromboembolismDong-Yi Chen, Chi-Nan Tseng, Ming-Jer Hsieh, et al.Plos One|March 11, 2015
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in TaiwanLi-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, et al.Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.Lab on a Chip|June 11, 2024
Site-specific thrombus formation: advancements in photothrombosis-on-a-chip technologyKuan-Ting Liu, Pai-Wen Wang, Han-Yun Hsieh, et al.Acta Cardiologica Sinica|May 28, 2026
2026 Expert Consensus Recommendations on Hypertrophic Cardiomyopathy: A Report of the Task Force of the Taiwan Society of CardiologyChung-Lieh Hung, Yen-Wen Wu, Chih-Hung Lai, et al.Current Cardiology Reports|August 16, 2021
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKDJohannes F E Mann, Tara I Chang, William C Cushman, et al.Journal of the American Heart Association|May 14, 2026
Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study)I-Chang Hsieh, Dong-Yi Chen, Chih-Sheng Chu, et al.The Prostate|July 1, 2021
Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro studyDong-Yi Chen, Po-Jung Su, Lai-Chu See, et al.Pageof 144